Physician profile
Charles T Carnel
NPI 1023228624
$1,967.90
in general payments reported to CMS, 2019-2025
21 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.40 · 2020: $227 · 2021: $277 · 2022: $273 · 2023: $195 · 2024: $473 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $554.34 | 2024-2025 | Excelsius3d Imaging System, Xlif, Pulse |
| Medtronic, INC. | $258.03 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nuvasive, INC. | $146.92 | 2019-2020 | |
| Cerapedics INC. | $141.65 | 2021 | |
| Medtronic USA, INC. | $139.95 | 2019-2020 | |
| Spinal Simplicity, LLC | $135.95 | 2023 | Ha Minuteman G3-R |
| Abbott Laboratories | $114.75 | 2022 | |
| Convatec INC. | $85.73 | 2022-2025 | |
| Spr Therapeutics, INC | $76.89 | 2025 | Sprint Pns System |
| Surgalign Spine Technologies, INC. | $60.52 | 2021 | |
| Depuy Synthes Sales INC. | $42.78 | 2024 | Dynacord, Truespan Orthocord, Healix Knotless Peek |
| Vertex Pharmaceuticals Incorporated | $38.68 | 2025 | |
| Abbvie INC. | $24.63 | 2023 | Botox |
| Conmed Corporation | $22.75 | 2025 | Visiclear, System 2450 |
| Heron Therapeutics, INC. | $21.05 | 2024 | Zynrelef |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $20.68 | 2024 | Exparel, Iovera |
| Becton, Dickinson and Company | $19.59 | 2025 | Arista |
| Pacira Therapeutics, INC. | $17.90 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2023 | Seglentis |
| Boston Scientific Corporation | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Carnel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.